Du Qing-You, Wang Xiao-Bo, Chen Xue-Jun, Zheng Wei, Wang Sheng-Qi
Beijing Institute of Radiation Med-icine, Beijing 100850, China.
World J Gastroenterol. 2003 Sep;9(9):2030-5. doi: 10.3748/wjg.v9.i9.2030.
To investigate the anti-tumor mechanism of antisense oligodeoxynucleotide cantide against hTERT.
Tumor cells were cultured overnight and grown to 50-60 % confluence. HepG2 and SMMC-7721 were treated with cantide mixed with lipofectin, or lipofectin alone. After inducted for 6 h at 37 degrees, 10 % FCS in DMEM was replaced in each well. After the treatment repeated twice to three times in each concentration of cantide, hTERT mRNA and protein expression were measured by RT-PCR and Western blot analysis, respectively. Telomerase activity was determined by TRAP-ELISA assay. CPP32- and ICE-like activity was also investigated using CasPACE assay system at 48 h after cantide treatment, and apoptosis was evaluated using the DeadEnd assay at 24, 48 and 72 h after cantide treatment.
Compared to the control cells, the cells treated with cantide showed a dose-dependent decrease in hTERT mRNA levels at 24 h and in protein levels at 48 h respectively. The telomerase activity was decreased as the concentration of cantide increased at 48 h. At the concentration of 800 nM, the telomerase activity in the treated HepG2 and SMMC-7721 cells was only 17.1 % (P<0.01) and 20.3 % (P<0.01) of that in untreated cells. The levels of CPP32-like protease activity in HepG2 and SMMC-7721 increased by 2.8- and 3.0-fold (P<0.05) at 48 h, and the levels of ICE-like protease activity also increased by 2.6- and 3.2-fold (P<0.05) respectively. The percentage of apoptosis in HepG2 and SMMC-7721 cells treated with 800 nM cantide at 72 h was 63 % and 52 % (P<0.01), respectively. By contrast, 8 % and 9 % of the cells were apoptosis after 72 h treatment with lipofectin alone.
Cantide can decrease telomerase activity by inhibiting the expression of hTERT gene and has a rapid anti-tumor effect through inducing the Caspase-dependent apoptosis. The rapid inhibitory effect of cantide on tumor growth demonstrates its feasibility in cancer treatment.
研究反义寡脱氧核苷酸坎地德针对人端粒酶逆转录酶(hTERT)的抗肿瘤机制。
将肿瘤细胞培养过夜,使其生长至50%-60%汇合度。用坎地德与脂质体混合或单独用脂质体处理HepG2和SMMC-7721细胞。在37℃诱导6小时后,每孔更换为含10%胎牛血清的DMEM。在每个坎地德浓度下重复处理两到三次后,分别通过逆转录-聚合酶链反应(RT-PCR)和蛋白质印迹分析检测hTERT mRNA和蛋白质表达。通过端粒重复序列扩增酶联免疫吸附测定(TRAP-ELISA)法测定端粒酶活性。在坎地德处理48小时后,还使用半胱天冬酶-3(CPP32)和ICE样活性检测系统研究CPP32和ICE样活性,并在坎地德处理24、48和72小时后使用DeadEnd检测法评估细胞凋亡情况。
与对照细胞相比,用坎地德处理的细胞在24小时时hTERT mRNA水平呈剂量依赖性下降,在48小时时蛋白质水平呈剂量依赖性下降。在48小时时,随着坎地德浓度增加,端粒酶活性降低。在800 nM浓度下,处理后的HepG2和SMMC-7721细胞中的端粒酶活性分别仅为未处理细胞的17.1%(P<0.01)和20.3%(P<0.01)。在48小时时,HepG2和SMMC-7721中CPP32样蛋白酶活性水平分别增加了2.8倍和3.0倍(P<0.05),ICE样蛋白酶活性水平也分别增加了2.6倍和3.2倍(P<0.05)。用800 nM坎地德处理72小时后,HepG2和SMMC-7721细胞的凋亡率分别为63%和52%(P<0.01)。相比之下,单独用脂质体处理72小时后,8%和9%的细胞发生凋亡。
坎地德可通过抑制hTERT基因表达降低端粒酶活性,并通过诱导半胱天冬酶依赖性凋亡产生快速抗肿瘤作用。坎地德对肿瘤生长的快速抑制作用证明了其在癌症治疗中的可行性。